GSK PLC GSK shares advanced 1.39% to £13.91 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.85% to 9,138.37. GSK PLC ...

The FTSE 100 index is seen trading at a new record after stock market sentiment was boosted by Japan’s trade deal with the US. IG Index futures point to a rise of about 0.5% to 9069 at today’s opening ...

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent seasonal influenza vaccines to US healthcare providers and pharmacies in preparation for the 2025-26 flu season.

Stock performance has followed, with the shares delivering a mind-boggling 300% gain since their market debut three months ago. That's compared with a 12% increase for the S&P 500.

For two weeks straight, shares of electric utility AES Corp. (NYSE: AES) stock have climbed, all on no obvious news -- but today we found out why this stock was hopping.

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.

Prediction: Alphabet's Stock Will Deliver Monster Performance Over the Next 2 Years July 06, 2025 — 05:30 am EDT Written by Keithen Drury for The Motley Fool -> ...